Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group.
Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, et al. Serruys PW, et al. Among authors: emanuelsson h. N Engl J Med. 1994 Aug 25;331(8):489-95. doi: 10.1056/NEJM199408253310801. N Engl J Med. 1994. PMID: 8041413 Free article. Clinical Trial.
Therapeutic dissection after successful coronary balloon angioplasty: no influence on restenosis or on clinical outcome in 693 patients. The MERCATOR Study Group (Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
Hermans WR, Rensing BJ, Foley DP, Deckers JW, Rutsch W, Emanuelsson H, Danchin N, Wijns W, Chappuis F, Serruys PW. Hermans WR, et al. Among authors: emanuelsson h. J Am Coll Cardiol. 1992 Oct;20(4):767-80. doi: 10.1016/0735-1097(92)90171-i. J Am Coll Cardiol. 1992. PMID: 1388181 Free article. Clinical Trial.
Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
Hermans WR, Rensing BJ, Foley DP, Tijssen JG, Rutsch W, Emanuelsson H, Danchin N, Wijns W, Chappuis F, Serruys PW. Hermans WR, et al. Among authors: emanuelsson h. J Cardiovasc Pharmacol. 1993;22 Suppl 4:S45-57. J Cardiovasc Pharmacol. 1993. PMID: 7523772 Clinical Trial.
Evaluation of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty. A multicenter randomized double-blind placebo-controlled trial.
Serruys PW, Klein W, Tijssen JP, Rutsch W, Heyndrickx GR, Emanuelsson H, Ball SG, Decoster O, Schroeder E, Liberman H, et al. Serruys PW, et al. Among authors: emanuelsson h. Circulation. 1993 Oct;88(4 Pt 1):1588-601. doi: 10.1161/01.cir.88.4.1588. Circulation. 1993. PMID: 8403306 Clinical Trial.
Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study.
Serruys PW, Emanuelsson H, van der Giessen W, Lunn AC, Kiemeney F, Macaya C, Rutsch W, Heyndrickx G, Suryapranata H, Legrand V, Goy JJ, Materne P, Bonnier H, Morice MC, Fajadet J, Belardi J, Colombo A, Garcia E, Ruygrok P, de Jaegere P, Morel MA. Serruys PW, et al. Among authors: emanuelsson h. Circulation. 1996 Feb 1;93(3):412-22. doi: 10.1161/01.cir.93.3.412. Circulation. 1996. PMID: 8565157 Clinical Trial.
Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II).
Serruys PW, van Hout B, Bonnier H, Legrand V, Garcia E, Macaya C, Sousa E, van der Giessen W, Colombo A, Seabra-Gomes R, Kiemeneij F, Ruygrok P, Ormiston J, Emanuelsson H, Fajadet J, Haude M, Klugmann S, Morel MA. Serruys PW, et al. Among authors: emanuelsson h. Lancet. 1998 Aug 29;352(9129):673-81. doi: 10.1016/s0140-6736(97)11128-x. Lancet. 1998. PMID: 9728982 Clinical Trial.
Evolution of coronary atherosclerosis in patients with mild coronary artery disease studied by serial quantitative coronary angiography at 2 and 4 years follow-up. The Multicenter Anti-Atheroma Study (MAAS) Investigators.
Vos J, de Feyter PJ, Kingma JH, Emanuelsson H, Legrand V, Winkelmann B, Dumont JM, Simoons LM. Vos J, et al. Among authors: emanuelsson h. Eur Heart J. 1997 Jul;18(7):1081-9. doi: 10.1093/oxfordjournals.eurheartj.a015401. Eur Heart J. 1997. PMID: 9243140 Free article.
Benestent II: back to the future.
Emanuelsson H, van der Giessen WJ, Serruys PW. Emanuelsson H, et al. J Interv Cardiol. 1994 Dec;7(6):587-92. doi: 10.1111/j.1540-8183.1994.tb00500.x. J Interv Cardiol. 1994. PMID: 10155208 Clinical Trial.
207 results